ArticleArchives of microbiology2026
The chemotaxis disruption of Aeromonas veronii by Lactococcus lactis and its probiotic effect on loach (Misgurnus anguillicaudatus).
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Aeromonas veronii is a pathogen that is widely found in aquaculture environments. It has been observed to colonize the gastrointestinal tract of fish and other aquatic animals, with the potential to cause severe infections. Previous studies have demonstrated that probiotics, such as Lactococcus lactis 01, Lactococcus lactis 02, Enterococcus pseudoavium 03, and Bacillus sp. 04, can reduce the colonization capability of A. veronii. In this study, we sought to ascertain whether these four probiotics could affect chemotaxis by interfering with N-acyl-homoserine lactones (AHLs), thereby regulating the intestinal colonization ability of A. veronii. The findings of this study demonstrate that the extracts of L. lactis 01, L. lactis 02, and E. pseudoavium 03 significantly attenuate the chemotactic behavior of A. veronii. It is noteworthy that L. lactis 01 exhibited a substantial capacity to impede A. veronii from producing AHLs, and a preliminary investigation into substances capable of inhibiting L. lactis 01. Furthermore, we observed that L. lactis 01 can ameliorate inflammation and oxidative stress induced by A. veronii colonization in the intestinal tract of loaches. Furthermore, genome analysis of L. lactis 01 confirmed that this strain is safe for practical application. These findings lay the foundation for further research into the molecular mechanisms underlying the interactions between probiotics and pathogens, offering novel perspectives for the development of probiotic-based biocontrol strategies.
Indexed as
Identifiers
42360434What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.